Hjem › Rhabdomyosarkom › Utah
Rhabdomyosarkom kliniske forsøg i Utah
4 studier for Rhabdomyosarkom søger deltagere på steder i Utah.
Byer i Utah
Officiel studietekst (engelsk)
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Primary Children's Hospital, Salt Lake City
RekruttererFase 1/2
Op til 30 år · Alle køn · Opdateret 3. sep. 2026 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Primary Children's Hospital, Salt Lake City
RekruttererFase 3
Op til 50 år · Alle køn · Opdateret 25. aug. 2026 · NCT07466316PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- University of Utah Hospital, Salt Lake City
RekruttererFase 1/2
Alder 1 til 30 · Alle køn · Opdateret 22. jul. 2026 · NCT06721689A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Primary Children's Hospital, Salt Lake City
RekruttererFase 2
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.